355 reports of this reaction
7.6% of all METHYLENE BLUE reports
#2 most reported adverse reaction
DRUG INTERACTION is the #2 most commonly reported adverse reaction for METHYLENE BLUE, manufactured by American Regent, Inc.. There are 355 FDA adverse event reports linking METHYLENE BLUE to DRUG INTERACTION. This represents approximately 7.6% of all 4,684 adverse event reports for this drug.
Patients taking METHYLENE BLUE who experience drug interaction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INTERACTION is moderately reported among METHYLENE BLUE users, representing a notable but not dominant share of adverse events.
In addition to drug interaction, the following adverse reactions have been reported for METHYLENE BLUE:
The following drugs have also been linked to drug interaction in FDA adverse event reports:
DRUG INTERACTION has been reported as an adverse event in 355 FDA reports for METHYLENE BLUE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INTERACTION accounts for approximately 7.6% of all adverse event reports for METHYLENE BLUE, making it one of the most commonly reported side effect.
If you experience drug interaction while taking METHYLENE BLUE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.